• 1
    Centers for Disease Control and Prevention. Prevalence and impact of chronic joint symptoms—seven states, 1996. MMWR Morb Mortal Wkly Rep 1998; 47: 34551.
  • 2
    Centers for Disease Control and Prevention. Arthritis prevalence and activity limitations—United States, 1990. MMWR Morb Mortal Wkly Rep 1994; 43: 4338.
  • 3
    Helmick CG, Lawrence RC, Pollard RA, Lloyd E, Heyse SP for the National Arthritis Data Work Group. Arthritis and other rheumatic conditions: who is affected now, who will be affected later? Arthritis Care Res 1995; 8: 20311.
  • 4
    Centers for Disease Control and Prevention. Prevalence of disabilities and associated health conditions among adults—United States, 1999. MMWR Morb Mortal Wkly Rep 2001; 50: 1205.
  • 5
    Yelin E, Callahan LF, for the National Arthritis Data Work Group. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995; 38: 135162.
  • 6
    Arthritis Foundation, Association of State and Territorial Health Officers, Centers for Disease Control and Prevention. National arthritis action plan: a public health strategy. Atlanta: Arthritis Foundation; 1999. p. 1.
  • 7
    Chartbook on work disability. Washington, DC: National Institute on Disability and Rehabilitation Research; 1991. p. 1132.
  • 8
    Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ. Weight loss reduces the risk of symptomatic knee osteoarthritis in women: the Framingham study. Ann Intern Med 1992; 116: 5359.
  • 9
    Minor M. Exercise in the treatment of osteoarthritis. Rheum Dis Clinics North Am 1999; 25: 397415.
  • 10
    Minor M. Arthritis and exercise: the times they are a-changn'. Arthritis Care Res 1996; 9: 7981.
  • 11
    Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum 1993; 36: 43946.
  • 12
    Koch H, Campbell W. The collection and processing of drug information: National Ambulatory Medical Care Survey, 1980. Vital Health Stat 1982; 2: 119.
  • 13
    Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments and emergency departments: United States, 1997. Vital Health Stat 1999; 13: 139.
  • 14
    Burt C, Knapp D. Ambulatory care visits for asthma: United States, 1993–1994. Adv Data Vital Health Stat 1996; 277: 120.
  • 15
    Verbrugge L, Patrick D. Seven chronic conditions: their impact on US adults' activity levels and use of medical services. Am J Public Health 1995; 85: 17382.
  • 16
    Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 77899.
  • 17
    Centers for Disease Control and Prevention. Health related quality of life among adults with arthritis—Behavioral Risk Factor Surveillance System, 11 states, 1996–1998. MMWR Morb Mortal Wkly Rep 2000; 49: 3669.
  • 18
    Mustard C, Kaufert P, Kozyrskyj A, Mayer T. Sex differences in the use of health care services. New Engl J Med 1998; 338: 167883.
  • 19
    Bertakis K, Azari R, Helms J, Callahan E, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract 2000; 49: 14752.
  • 20
    Green C, Pope C. Gender, psychosocial factors and the use of medical services: a longitudinal analysis. Soc Sci Med 1999; 48: 136372.
  • 21
    Saag KG, Doebbeling BN, Rohrer JE, Kolluri S, Mitchell TA, Wallace RB. Arthritis health service utilization among the elderly: the role of urban-rural residence and other utilization factors. Arthritis Care Res 1998; 11: 17785.
  • 22
    Agarwal AK, Eisenbeis CH, Dishart PW, Britz PA. Rheumatology training for rheumatology fellows and nonrheumatologists: comment on the editorial by Stross [letter]. Arthritis Rheum 1993; 36: 2845.
  • 23
    Stross JK. Rheumatologists as an endangered species: a proposal for change. Arthritis Rheum 1992; 35: 60910.
  • 24
    Centers for Disease Control and Prevention. Prevalence of leisure-time physical activity among persons with arthritis and other rheumatic conditions—United States, 1990–1991. MMWR Morb Mortal Wkly Rep 1997; 46: 38993.
  • 25
    Chrisodoulakis M, Spyridakis M, Michaloudis D, Papvasiliou E, Tsiftsis D. Disorders associated with clinically severe obesity: significant improvement after surgical weight reduction. South Med J 1998; 91: 11438.
  • 26
    Toda Y, Toda T, Takemura S, Wada T, Morimoto T, Ogawa R. Change in body fat, but not body weight or metabolic correlates of obesity, is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program. J Rheumatol 1998; 25: 21816.
  • 27
    U.S. Department of Health and Human Services. Physical activity and health: a report of the Surgeon General. Atlanta: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion; 1996. p. 12930.
  • 28
    Sandstrom MJ, Keefe FJ. Self-management of fibromyalgia: the role of formal coping skills training and physical exercise training programs. Arthritis Care Res 1998; 11: 43247.
  • 29
    Ward N. Trends in the use of disease modifying antirheumatic medications in rheumatoid arthritis, 1980–1995: results from the National Ambulatory Medical Care Surveys. J Rheumatol 1999; 26: 54650.
  • 30
    Lanes SF, Lanza LL, Radensky PW, Yood RA, Meenan RF, Walker AM, et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum 1997; 40: 147581.
  • 31
    Wolfe M, Lichtenstein D, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. New Engl J Med 1999; 340: 188899.
  • 32
    Gabriel S, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to the use of nonsteroi-dal anti-inflammatory drugs: a meta-analysis. Ann Intern Med 1991; 115: 78796.
  • 33
    Singh G, Triadafilopoulis G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol 1999; 26 Suppl: 1824.
  • 34
    Bloom B. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis. Am J Med 1988; 84: 204.
  • 35
    Greene J, Winickoff R. Cost-conscious prescribing of non-steroidal antiinflammatory drugs for adults with arthritis: a review and suggestions. Arch Intern Med 1992; 152: 19952002.
  • 36
    Tamblyn R, Berkson L, Dauphinee W, Gayton D, Grad R, Huang A, et al. Unnecessary prescribing of NSAIDs and the management of NSAID-related gastropathy in medical practice. Ann Intern Med 1997; 127: 42938.
  • 37
    Rao J, Callahan L, Helmick C. Characteristics of persons with self-reported arthritis and other rheumatic conditions who do not see a doctor. J Rheumatol 1997; 24: 16973.